(Q41574130)

4 October 2017

1 reference

title

Maternal and fetal implications of anticonvulsive therapy during pregnancy (English)

1 reference

4 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9266576

12 November 2024

author name string

D. P. Eller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9266576

12 November 2024

C. A. Patterson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9266576

12 November 2024

G. W. Webb

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9266576

12 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9266576

12 November 2024

publication date

1 September 1997

1 reference

4 October 2017

September 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9266576

full work available at URL

12 November 2024

https://api.elsevier.com/content/article/PII:S088985450570320X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0889-8545(05)70320-X

https://api.elsevier.com/content/article/PII:S088985450570320X?httpAccept=text/plain

12 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8545(05)70320-X

Obstetrics and Gynecology Clinics of North America

12 November 2024

published in

1 reference

4 October 2017

volume

24

1 reference

4 October 2017

issue

3

1 reference

4 October 2017

page(s)

523-534

1 reference

Seizure Disorders in Offspring of Parents with a History of Seizures—A Maternal‐Paternal Difference?

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

1 reference

7 January 2021

Reproductive function in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Maternal barbiturate utilization and neonatal withdrawal symptomatology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Facial clefts in sibs and children of epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Minor anomalies in offspring of epileptic mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

The fetal hydantoin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Epilepsy and clefting disorders: lack of evidence of a familial association

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Obstetric outcome in women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Initiation and duration of breast-feeding in women receiving antiepileptics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Pattern of malformations in the children of women treated with carbamazepine during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

A register study of maternal epilepsy and delivery outcome with special reference to drug use

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Teratogenicity of antiepileptic drugs: analysis of possible risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Teratogenicity of anticonvulsant drugs. IV: The association of clefting and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Infantile spasms on weaning from breast milk containing anticonvulsants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Plasma antiepileptic drug concentrations during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

In-utero exposure to valproate and neural tube defects.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Maternal seizure disorder, outcome of pregnancy, and neurologic abnormalities in the children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

In utero exposure to phenobarbital and intelligence deficits in adult men.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Spina bifida in infants of women treated with carbamazepine during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Epilepsy and pregnancy--a review of 98 pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Problems and management of the pregnant woman with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970320-X

7 January 2021

Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects

8

1 reference

https://api.crossref.org/works/10.1016/S0889-8545(05)70320-X

Clinical and experimental studies linking oxidative metabolism to phenytoin-induced teratogenesis

12 November 2024

14

1 reference

https://api.crossref.org/works/10.1016/S0889-8545(05)70320-X

Psychomotor development in children of mothers with epilepsy

12 November 2024

17

1 reference

https://api.crossref.org/works/10.1016/S0889-8545(05)70320-X

12 November 2024

Neurologic disorders

38

1 reference

https://api.crossref.org/works/10.1016/S0889-8545(05)70320-X

Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis

12 November 2024

41

1 reference

https://api.crossref.org/works/10.1016/S0889-8545(05)70320-X

Antiepileptics and the development of congenital anomalies

12 November 2024

46

1 reference

https://api.crossref.org/works/10.1016/S0889-8545(05)70320-X

12 November 2024

Identifiers

1 reference

4 October 2017

1 reference